{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:12:44Z","timestamp":1715386364475},"reference-count":21,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22024","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T22:10:59Z","timestamp":1672179059000},"page":"253-257","source":"Crossref","is-referenced-by-count":0,"title":["Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma"],"prefix":"10.3960","volume":"62","author":[{"given":"Komei","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Hachiya","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"},{"name":"Department of Hematology, Matsusaka Chuo General Hospital, Matsusaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Tono","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tamaru","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[{"name":"Pathology Division, Mie University Hospital, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Kurume, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinaga","family":"Okugawa","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine, Mie University Hospital, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Swerdlow SH. International Agency for Research on C: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer. 2017."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Hung YP, Qian X. Histiocytic Sarcoma. Arch Pathol Lab Med. 2020; 144: 650-654.","DOI":"10.5858\/arpa.2018-0349-RS"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Eberle FC, Rodriguez-Canales J, Wei L <i>et al.<\/i> Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica. 2011; 96: 558-566.","DOI":"10.3324\/haematol.2010.033167"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kritharis A, Pilichowska M, Evens AM. How I manage patients with grey zone lymphoma. Br J Haematol. 2016; 174: 345-350.","DOI":"10.1111\/bjh.14174"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Shanmugam V, Griffin GK, Jacobsen ED <i>et al.<\/i> Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019; 32: 830-843.","DOI":"10.1038\/s41379-018-0200-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hornick JL, Jaffe ES, Fletcher CDM. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004; 28: 1133-1144.","DOI":"10.1097\/01.pas.0000131541.95394.23"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yoshida C, Takeuchi M. Histiocytic sarcoma: identification of its histiocytic origin using immunohistochemistry. Intern Med. 2008; 47: 165-169.","DOI":"10.2169\/internalmedicine.47.0386"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tsujimura H, Miyaki T, Yamada S <i>et al.<\/i> Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation. Int J Hematol. 2014; 100: 507-510.","DOI":"10.1007\/s12185-014-1630-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sarkozy C, Hung SS, Chavez EA <i>et al.<\/i> Mutational landscape of gray zone lymphoma. Blood. 2021; 137: 1765-1776.","DOI":"10.1182\/blood.2020007507"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Mellert K, Martin M, Lennerz JK <i>et al.<\/i> The impact of SOCS1 mutations in diffuse large B-cell lymphoma. Br J Haematol. 2019; 187: 627-637.","DOI":"10.1111\/bjh.16147"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Camus V, Miloudi H, Taly A, Sola B, Jardin F. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. J Hematol Oncol. 2017; 10: 47.","DOI":"10.1186\/s13045-017-0412-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mottok A, Hung SS, Chavez EA <i>et al.<\/i> Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood. 2019; 134: 802-813.","DOI":"10.1182\/blood.2019001126"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tiacci E, Ladewig E, Schiavoni G <i>et al.<\/i> Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood. 2018; 131: 2454-2465.","DOI":"10.1182\/blood-2017-11-814913"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Sarkozy C, Chong L, Takata K <i>et al.<\/i> Gene expression profiling of gray zone lymphoma. Blood Adv. 2020; 4: 2523-2535.","DOI":"10.1182\/bloodadvances.2020001923"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sarkozy C, Copie-Bergman C, Damotte D <i>et al.<\/i> Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA. Am J Surg Pathol. 2019; 43: 341-351.","DOI":"10.1097\/PAS.0000000000001198"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sarkozy C, Molina T, Ghesqui\u00e8res H <i>et al.<\/i> Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 2017; 102: 150-159.","DOI":"10.3324\/haematol.2016.152256"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Evens AM, Kanakry JA, Sehn LH <i>et al.<\/i> Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol. 2015; 90: 778-783.","DOI":"10.1002\/ajh.24082"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Connors JM, Jurczak W, Straus DJ <i>et al.<\/i> Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin\u2019s Lymphoma. N Engl J Med. 2018; 378: 331-344.","DOI":"10.1056\/NEJMoa1708984"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Svoboda J, Bair SM, Landsburg DJ <i>et al.<\/i> Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Haematologica. 2021; 106: 1705-1713.","DOI":"10.3324\/haematol.2019.238675"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Mallipudi RM, Alquran L, Shenoy VA, Leslie LA, Conti JA. A rare case of grey zone lymphoma successfully treated with Brentuximab vedotin and R-CHP chemotherapy. Case Rep Oncol Med. 2019; 2019: 4121234.","DOI":"10.1155\/2019\/4121234"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Li J, Sim J, Leung AYH, Kwong YL. Favorable response of relapsed\/refractory gray-zone lymphoma to brentuximab vedotin. Ann Hematol. 2018; 97: 551-554.","DOI":"10.1007\/s00277-017-3179-3"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22024\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:18:12Z","timestamp":1715318292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/4\/62_22024\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22024","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22024"}}